Aavis Pharmaceuticals Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 33

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.1M

Aavis Pharmaceuticals General Information


Operator of a pharmaceutical company intended to engage in contract development and manufacturing of generic pharmaceuticals. The company develops niche generic drugs with expertise in development, including advanced scientific research, process development, patent analysis, regulatory compliance and market and competition analysis, providing healthcare clients and customers with affordable generic medicines that can enable patients to live healthier, and more productive lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • P.O. Box 609
  • Hoschton, GA 30548
  • United States
+1 (706) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aavis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 24-Oct-2017 $1.1M 00.000 00.00 Completed Product Development
2. Seed Round 10-Aug-2015 00.000 00.000 Completed Product Development
1. Capitalization 01-Jan-2015 $1.2M $1.2M Completed Product Development
To view Aavis Pharmaceuticals’s complete valuation and funding history, request access »

Aavis Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Dhananjay Barot President
You’re viewing 1 of 2 executive team members. Get the full list »

Aavis Pharmaceuticals Board Members (6)

Name Representing Role Since
Ashok Barot Self Chairman 000 0000
Gaurang Desai Aavis Pharmaceuticals Board Member 000 0000
Pankaj Chaudhari Aavis Pharmaceuticals Board Member 000 0000
Ravi Patel Self Board Member 000 0000
Swapnil Shah Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Aavis Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial